Form D · Pharmaceuticals
Abeona Therapeutics LLC
Cleveland, OH · CIK 0001612434
Offering snapshot reported Nov 7, 2014 · SEC filing
- Reported sold
- $3.61M Offering amount: $5M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 31, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 7, 2014 | Initial | $3,612,500 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-227909
Source: Form D, filed Nov 7, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Al Hawkins | Director, Executive |
| Timothy Miller | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
10000 Cedar Avenue
Cleveland, OH, 44106
Cleveland, OH, 44106